These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

119 related items for PubMed ID: 6096348

  • 1.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 2. Correlation of predicted serum bactericidal activities and values measured in volunteers.
    Drusano G, Standiford H, Ryan P, McNamee W, Tatem B, Schimpff S.
    Eur J Clin Microbiol; 1986 Feb; 5(1):88-92. PubMed ID: 3084247
    [Abstract] [Full Text] [Related]

  • 3.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 4. [Susceptibility of clinical isolates to cefotaxime. Comparison to new antibiotics latamoxef, cefoperazone, and ceftizoxime].
    Asari S, Horikawa M, Tsukamoto H, Shimizu Y, Koda K, Hayashi C, Miyai K.
    Jpn J Antibiot; 1984 Feb; 37(2):267-78. PubMed ID: 6330393
    [Abstract] [Full Text] [Related]

  • 5. The effects of latamoxef, cefotaxime, and cefoperazone on platelet function and coagulation in normal volunteers.
    Weitekamp MR, Caputo GM, Al-Mondhiry HA, Aber RC.
    J Antimicrob Chemother; 1985 Jul; 16(1):95-101. PubMed ID: 4044467
    [Abstract] [Full Text] [Related]

  • 6.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 7.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 8.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 9. [The antibacterial activity of new cephem antibiotics against clinical isolates. A comparison of the antibacterial activity of cefotaxime with 6 other antibiotics].
    Miwatani T, Takeda Y, Kotera K, Nishimura T, Takashima T, Hiromatsu K, Tabuki K, Fujimoto S, Kamiki T, Yoshizaki E, Yabuuchi E, Shimizu Y, Matsunaga K, Yamanaka K, Furuta I, Iimori M, Kodama J, Tanaka M, Maejima K, Nukina M, Takashima E, Takahashi M, Harikane O, Masutani T.
    Jpn J Antibiot; 1983 Feb; 36(2):260-76. PubMed ID: 6304368
    [Abstract] [Full Text] [Related]

  • 10.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 11.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 12. Activity of third-generation cephalosporins in human blood.
    Shah PM, Jaenisch E.
    Clin Ther; 1983 Feb; 6(1):72-8. PubMed ID: 6325006
    [Abstract] [Full Text] [Related]

  • 13. [Comparison of antimicrobial activity and stability to beta-lactamases of cefoperazone, cefotaxime, lamoxactam and ceftriaxon].
    Baumgärtner M, Grehn M, Wundt W.
    Zentralbl Bakteriol Mikrobiol Hyg A Med Mikrobiol Infekt Parasitol; 1982 Jun; 252(2):208-21. PubMed ID: 6289564
    [Abstract] [Full Text] [Related]

  • 14.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 15.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 16. Comparison of the pharmacokinetics of ceftazidime and moxalactam and their microbiological correlates in volunteers.
    Drusano GL, Standiford HC, Fitzpatrick B, Leslie J, Tangtatsawasdi P, Ryan P, Tatem B, Moody MR, Schimpff SC.
    Antimicrob Agents Chemother; 1984 Sep; 26(3):388-93. PubMed ID: 6391372
    [Abstract] [Full Text] [Related]

  • 17.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 18.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 19.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 20. In vitro comparison of three new cephalosporins: LY-127935, cefotaxime and cefoperazone.
    Trager GM, White GW, Zimelis VM, Bryk DA, Panwalker AP.
    Chemotherapy; 1981 Sep; 27(1):34-8. PubMed ID: 6260435
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 6.